Copyright © 2001 by the European Society of Cardiology.
Letters to the Editor
Arginine intake and 25-year CHD mortality: the Seven Countries Study
a Department of Chronic Diseases Epidemiology, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
b Department of Human Nutrition and Epidemiology, Wageningen University, Wageningen, The Netherlands
c Laboratory of Organic Chemistry, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
d Division of Epidemiology, School of Public Health, University of Minnesota, Minneapolis, U.S.A.
e Division of Public Health Research, National Institute of Public Health and the Environment, Bilthoven, The Netherlands
References
- Meyer EC, Palant A. Arginine consumption in coronary disease. (Letter). Eur Heart J. 1998;19:970971[Medline]
- Cooke JP, Singer AH, Tsao P, Zera P, Rowan RA, Billingham ME. Antiatherogenic effects of L-arginine in the hypercholesterolemic rabbit. J Clin Invest. 1992;90:11681172[ISI][Medline]
- Adams MR, McCredie R, Jessup W, Robinson J, Sullivan D, Celermajer DS. Oral L-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery disease. Atherosclerosis. 1997;129:261269[CrossRef][ISI][Medline]
- Oomen CM, van Erk MJ, Feskens EJM, Kok FJ, Kromhout D. Arginine intake and the risk of coronary heart disease mortality in elderly men. Arterioscler Thromb Vasc Biol. 2000;20:21342139
[Abstract/Free Full Text] - Hertog MGL, Kromhout D, Aravanis C. Flavonoid intake and risk for coronary heart disease and cancer in the Seven Countries Study. Arch Intern Med. 1995;155:381386[Abstract]
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||